Adverse Prognosis of Patients With Septal Substrate After VT Ablation Due to Electrical Storm
- PMID: 36951814
- DOI: 10.1016/j.jacep.2023.01.012
Adverse Prognosis of Patients With Septal Substrate After VT Ablation Due to Electrical Storm
Abstract
Background: Data about ventricular tachycardia (VT) ablation in patients with electrical storm (ES) is limited.
Objectives: This study sought to compare the prognostic outcome of patients undergoing VT ablation after ES with and without a septal substrate.
Methods: In this large single-center study, consecutive patients presenting with ES and undergoing VT ablation from June 2018 to April 2021 were included. Patients with septal substrate were compared with patients without septal substrate regarding endpoints of cardiovascular mortality, VT recurrences, recurrences of the clinical VT, and rehospitalization rates.
Results: A total of 107 patients undergoing a first VT ablation because of electrical storm (ES) were included (age 65 ± 13 years, 86% male, 45% ischemic cardiomyopathy). Major complications occurred in 11% of all patients with increased postinterventional third-degree atrioventricular blocks among patients with septal substrate (9% vs 0%; P = 0.063). Partial ablation successes were similar (95% with a septal substrate vs 100% without a septal substrate; P = 0.251). Complete ablation success was achieved in 63% with a septal substrate and in 87% without a septal substrate (P = 0.004). After a median 22 months of follow-up, patients with septal substrate died significantly more often from cardiovascular causes (26% vs 7%; log-rank P = 0.018). In univariate analysis cardiovascular mortality for ES patients with septal substrate was 4.1-fold higher (HR: 4.192; CI: 1.194-14.719; P = 0.025). Independent predictors of adverse outcome in multivariable regression analysis were presence of septal substrate (HR: 5.723; P = 0.025) and increased age (HR: 1.104; P = 0.003). Recurrences of any ventricular arrhythmia (67% vs 56%; log rank P = 0.554) and rehospitalization rates (80% vs 66%; log rank P = 0.515) were similar between groups. Recurrences of clinical VT were similar (7% vs 2%; P = 0.252).
Conclusions: Presence of a septal substrate is associated with adverse long-term cardiovascular mortality in patients admitted for VT ablation after ES. Despite decreased acute ablation successes in these patients, VT recurrence rates were similar to those without a septal substrate during follow-up.
Keywords: ablation; electrical storm; mortality; septal substrate.
Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment in
-
Septal Substrate in Ventricular Tachycardia Storm: Bellwether of Risk.JACC Clin Electrophysiol. 2023 Jun;9(6):805-807. doi: 10.1016/j.jacep.2023.03.012. Epub 2023 May 24. JACC Clin Electrophysiol. 2023. PMID: 37227352 No abstract available.
Similar articles
-
Electrical Storm Has Worse Prognosis Compared to Sustained Ventricular Tachycardia after VT Ablation.J Clin Med. 2023 Apr 6;12(7):2730. doi: 10.3390/jcm12072730. J Clin Med. 2023. PMID: 37048813 Free PMC article.
-
Prediction and prognosis of ventricular tachycardia recurrence after catheter ablation with remote magnetic navigation for electrical storm in patients with ischemic cardiomyopathy.Clin Cardiol. 2017 Nov;40(11):1083-1089. doi: 10.1002/clc.22773. Epub 2017 Aug 17. Clin Cardiol. 2017. PMID: 28817194 Free PMC article.
-
Successful ventricular tachycardia ablation in patients with electrical storm reduces recurrences and improves survival.Heart Rhythm. 2018 Jan;15(1):48-55. doi: 10.1016/j.hrthm.2017.08.022. Epub 2017 Aug 24. Heart Rhythm. 2018. PMID: 28843418
-
Catheter Ablation for Ventricular Tachycardia in Ischaemic Versus Non-Ischaemic Cardiomyopathy: A Systematic Review and Meta-Analysis.Heart Lung Circ. 2022 Aug;31(8):1064-1074. doi: 10.1016/j.hlc.2022.02.014. Epub 2022 May 25. Heart Lung Circ. 2022. PMID: 35643798
-
Catheter ablation versus medical therapy for treatment of ventricular tachycardia associated with structural heart disease: Systematic review and meta-analysis of randomized controlled trials and comparison with observational studies.Heart Rhythm. 2019 Oct;16(10):1484-1491. doi: 10.1016/j.hrthm.2019.05.026. Epub 2019 May 29. Heart Rhythm. 2019. PMID: 31150816
Cited by
-
Impact of repeat ablation of ventricular tachycardia in patients with structural heart disease.Europace. 2023 Dec 28;26(1):euad367. doi: 10.1093/europace/euad367. Europace. 2023. PMID: 38127308 Free PMC article.
-
Pre-ablation and Post-ablation Factors Influencing the Prognosis of Patients with Electrical Storm Treated by Radiofrequency Catheter Ablation: An Update.Rev Cardiovasc Med. 2024 Dec 5;25(12):432. doi: 10.31083/j.rcm2512432. eCollection 2024 Dec. Rev Cardiovasc Med. 2024. PMID: 39742218 Free PMC article. Review.
-
Management of ventricular tachycardias: insights on centre settings, procedural workflow, endpoints, and implementation of guidelines-results from an EHRA survey.Europace. 2024 Feb 1;26(2):euae030. doi: 10.1093/europace/euae030. Europace. 2024. PMID: 38363995 Free PMC article.
-
A screening for cerebral deoxygenation during VT ablations in patients with structural heart disease.Clin Res Cardiol. 2025 Apr;114(4):481-491. doi: 10.1007/s00392-024-02493-4. Epub 2024 Jul 16. Clin Res Cardiol. 2025. PMID: 39012507 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous